InfuSystem Holdings, Inc. Acquires Star Infusion
MADISON HEIGHTS, Mich., March 10, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading national provider of infusion pumps and related services, announced today that it has acquired Michigan-based Star Infusion and Compression Therapies LLC ("Star Infusion"). Star Infusion is a provider of ambulatory infusion pumps and related services to oncologists in Michigan and Ohio.
Sean McDevitt, Chairman and CEO of InfuSystem, said, "Star Infusion has developed a loyal customer following and we welcome those oncology practices and their patients to InfuSystem. We are very pleased with the synergies this acquisition provides and it further solidifies and enhances InfuSystem's leading national position in the ambulatory infusion market."
The acquisition, which was for cash, is not expected to materially impact the Company's fiscal 2011 consolidated financial performance. Further details of the acquisition were not disclosed.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company's stock is traded on the NYSE Amex under the symbol INFU.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
CONTACT: Investor Contact:
Pat LaVecchia
Vice Chairman
Info@InfuSystem.com
800-962-9656
Source: InfuSystem, Inc.
Recent INFU News
- InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 08:30:00 PM
- InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K • Business Wire • 04/03/2024 10:30:00 AM
- InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023 • Business Wire • 03/14/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 11:31:20 AM
- InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 • Business Wire • 03/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:00:52 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:29:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:51:18 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/29/2023 10:08:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:30:42 PM
- InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023 • Business Wire • 11/28/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:01:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:39:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:16:50 PM
- InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023 • Business Wire • 11/09/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 11:31:00 AM
- InfuSystem Reports Third Quarter 2023 Financial Results • Business Wire • 11/07/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 10:41:12 AM
- InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023 • Business Wire • 10/31/2023 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:51:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 10:38:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM